Enasidenib is a drug used to treat relapsed or refractory?acute myeloid leukemia?in people with specific mutations of the?isocitrate dehydrogenase 2?(IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
This report aims to provide a comprehensive presentation of the global market for Enasidenib Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enasidenib Drugs. This report contains market size and forecasts of Enasidenib Drugs in global, including the following market information:
Global Enasidenib Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Enasidenib Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Enasidenib Drugs companies in 2022 (%)
The global Enasidenib Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
50mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Enasidenib Drugs include Celgene Corporation. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Enasidenib Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Enasidenib Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Enasidenib Drugs Market Segment Percentages, by Type, 2022 (%)
50mg
100mg
Global Enasidenib Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Enasidenib Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Global Enasidenib Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Enasidenib Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Enasidenib Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Enasidenib Drugs revenues share in global market, 2022 (%)
Key companies Enasidenib Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Enasidenib Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Celgene Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Enasidenib Drugs, market overview.
Chapter 2: Global Enasidenib Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Enasidenib Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Enasidenib Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Enasidenib Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Enasidenib Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Enasidenib Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Enasidenib Drugs Overall Market Size
2.1 Global Enasidenib Drugs Market Size: 2022 VS 2029
2.2 Global Enasidenib Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Enasidenib Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Enasidenib Drugs Players in Global Market
3.2 Top Global Enasidenib Drugs Companies Ranked by Revenue
3.3 Global Enasidenib Drugs Revenue by Companies
3.4 Global Enasidenib Drugs Sales by Companies
3.5 Global Enasidenib Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Enasidenib Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Enasidenib Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Enasidenib Drugs Players in Global Market
3.8.1 List of Global Tier 1 Enasidenib Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Enasidenib Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Enasidenib Drugs Market Size Markets, 2022 & 2029
4.1.2 50mg
4.1.3 100mg
4.2 By Type - Global Enasidenib Drugs Revenue & Forecasts
4.2.1 By Type - Global Enasidenib Drugs Revenue, 2018-2023
4.2.2 By Type - Global Enasidenib Drugs Revenue, 2024-2029
4.2.3 By Type - Global Enasidenib Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Enasidenib Drugs Sales & Forecasts
4.3.1 By Type - Global Enasidenib Drugs Sales, 2018-2023
4.3.2 By Type - Global Enasidenib Drugs Sales, 2024-2029
4.3.3 By Type - Global Enasidenib Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Enasidenib Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Enasidenib Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application - Global Enasidenib Drugs Revenue & Forecasts
5.2.1 By Application - Global Enasidenib Drugs Revenue, 2018-2023
5.2.2 By Application - Global Enasidenib Drugs Revenue, 2024-2029
5.2.3 By Application - Global Enasidenib Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Enasidenib Drugs Sales & Forecasts
5.3.1 By Application - Global Enasidenib Drugs Sales, 2018-2023
5.3.2 By Application - Global Enasidenib Drugs Sales, 2024-2029
5.3.3 By Application - Global Enasidenib Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Enasidenib Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Enasidenib Drugs Market Size, 2022 & 2029
6.2 By Region - Global Enasidenib Drugs Revenue & Forecasts
6.2.1 By Region - Global Enasidenib Drugs Revenue, 2018-2023
6.2.2 By Region - Global Enasidenib Drugs Revenue, 2024-2029
6.2.3 By Region - Global Enasidenib Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Enasidenib Drugs Sales & Forecasts
6.3.1 By Region - Global Enasidenib Drugs Sales, 2018-2023
6.3.2 By Region - Global Enasidenib Drugs Sales, 2024-2029
6.3.3 By Region - Global Enasidenib Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Enasidenib Drugs Revenue, 2018-2029
6.4.2 By Country - North America Enasidenib Drugs Sales, 2018-2029
6.4.3 US Enasidenib Drugs Market Size, 2018-2029
6.4.4 Canada Enasidenib Drugs Market Size, 2018-2029
6.4.5 Mexico Enasidenib Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Enasidenib Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Enasidenib Drugs Sales, 2018-2029
6.5.3 Germany Enasidenib Drugs Market Size, 2018-2029
6.5.4 France Enasidenib Drugs Market Size, 2018-2029
6.5.5 U.K. Enasidenib Drugs Market Size, 2018-2029
6.5.6 Italy Enasidenib Drugs Market Size, 2018-2029
6.5.7 Russia Enasidenib Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Enasidenib Drugs Market Size, 2018-2029
6.5.9 Benelux Enasidenib Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Enasidenib Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Enasidenib Drugs Sales, 2018-2029
6.6.3 China Enasidenib Drugs Market Size, 2018-2029
6.6.4 Japan Enasidenib Drugs Market Size, 2018-2029
6.6.5 South Korea Enasidenib Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Enasidenib Drugs Market Size, 2018-2029
6.6.7 India Enasidenib Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Enasidenib Drugs Revenue, 2018-2029
6.7.2 By Country - South America Enasidenib Drugs Sales, 2018-2029
6.7.3 Brazil Enasidenib Drugs Market Size, 2018-2029
6.7.4 Argentina Enasidenib Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Enasidenib Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Enasidenib Drugs Sales, 2018-2029
6.8.3 Turkey Enasidenib Drugs Market Size, 2018-2029
6.8.4 Israel Enasidenib Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Enasidenib Drugs Market Size, 2018-2029
6.8.6 UAE Enasidenib Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Celgene Corporation
7.1.1 Celgene Corporation Company Summary
7.1.2 Celgene Corporation Business Overview
7.1.3 Celgene Corporation Enasidenib Drugs Major Product Offerings
7.1.4 Celgene Corporation Enasidenib Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Celgene Corporation Key News & Latest Developments
8 Global Enasidenib Drugs Production Capacity, Analysis
8.1 Global Enasidenib Drugs Production Capacity, 2018-2029
8.2 Enasidenib Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Enasidenib Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Enasidenib Drugs Supply Chain Analysis
10.1 Enasidenib Drugs Industry Value Chain
10.2 Enasidenib Drugs Upstream Market
10.3 Enasidenib Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Enasidenib Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Enasidenib Drugs in Global Market
Table 2. Top Enasidenib Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Enasidenib Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Enasidenib Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Enasidenib Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Enasidenib Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Enasidenib Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Enasidenib Drugs Product Type
Table 9. List of Global Tier 1 Enasidenib Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Enasidenib Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Enasidenib Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Enasidenib Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Enasidenib Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Enasidenib Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Enasidenib Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Enasidenib Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Enasidenib Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Enasidenib Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Enasidenib Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Enasidenib Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Enasidenib Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Enasidenib Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Enasidenib Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Enasidenib Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Enasidenib Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Enasidenib Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Enasidenib Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Enasidenib Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Enasidenib Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Enasidenib Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Enasidenib Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Enasidenib Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Enasidenib Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Enasidenib Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Enasidenib Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Enasidenib Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Enasidenib Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Enasidenib Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Enasidenib Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Enasidenib Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Enasidenib Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Enasidenib Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Enasidenib Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Enasidenib Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Enasidenib Drugs Sales, (K Units), 2024-2029
Table 46. Celgene Corporation Company Summary
Table 47. Celgene Corporation Enasidenib Drugs Product Offerings
Table 48. Celgene Corporation Enasidenib Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Celgene Corporation Key News & Latest Developments
Table 50. Enasidenib Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global Enasidenib Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Enasidenib Drugs Production by Region, 2018-2023 (K Units)
Table 53. Global Enasidenib Drugs Production by Region, 2024-2029 (K Units)
Table 54. Enasidenib Drugs Market Opportunities & Trends in Global Market
Table 55. Enasidenib Drugs Market Drivers in Global Market
Table 56. Enasidenib Drugs Market Restraints in Global Market
Table 57. Enasidenib Drugs Raw Materials
Table 58. Enasidenib Drugs Raw Materials Suppliers in Global Market
Table 59. Typical Enasidenib Drugs Downstream
Table 60. Enasidenib Drugs Downstream Clients in Global Market
Table 61. Enasidenib Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Enasidenib Drugs Segment by Type in 2022
Figure 2. Enasidenib Drugs Segment by Application in 2022
Figure 3. Global Enasidenib Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Enasidenib Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Enasidenib Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Enasidenib Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Enasidenib Drugs Revenue in 2022
Figure 9. By Type - Global Enasidenib Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Enasidenib Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Enasidenib Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Enasidenib Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Enasidenib Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Enasidenib Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Enasidenib Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Enasidenib Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Enasidenib Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Enasidenib Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Enasidenib Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Enasidenib Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Enasidenib Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Enasidenib Drugs Sales Market Share, 2018-2029
Figure 23. US Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Enasidenib Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Enasidenib Drugs Sales Market Share, 2018-2029
Figure 28. Germany Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Enasidenib Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Enasidenib Drugs Sales Market Share, 2018-2029
Figure 37. China Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Enasidenib Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Enasidenib Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Enasidenib Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Enasidenib Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Enasidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Enasidenib Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Enasidenib Drugs by Region, 2022 VS 2029
Figure 54. Enasidenib Drugs Industry Value Chain
Figure 55. Marketing Channels
